company

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

as of 2026-07-01
Monitor thisAsk about this
at a glance
5 trials sponsored · 6 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

6 assets
OlanzapineLorcaserinMetforminNaltrexonePremier Lifestyle Intervention with DASH DietTEAMcare treatment of diabetes

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Olanzapine
small molecule
drug
Lorcaserin
small molecule
drug
Metformin
small molecule
drug
Naltrexone
small molecule
drug
Premier Lifestyle Intervention with DASH Diet
BEHAVIORAL
drug
TEAMcare treatment of diabetes
OTHER
drug